AbbVie to Lower Drug Prices Under Trump Deal, Expands TrumpRx Access, Commits USD 100 Billion
This three-year agreement provides ​AbbVie with exemption from tariffs and future pricing ‌mandates, the ‍company said, adding that further terms ‍of the deal remain confidential.